Research Paper Volume 16, Issue 9 pp 7578—7595
Establishment and verification of a prognostic model based on coagulation and fibrinolysis-related genes in hepatocellular carcinoma
Figure 6. Immunological abnormalities and drug susceptibility between RiskScore groups. (A) Differences in immune infiltration by CIBERSORT algorithm; (B) Differences in immune score by TIMER; (C) Analysis of immune checkpoint gene expression; (D) Differences in the expression of immunomodulators; (E) Correlation between RiskScore and TIDE score; (F) Comparison of drug sensitivity between different RiskScore groups.